SM-2256

N/A

Report date: 2024/11/20 15:22:05

Base Information

Drug NameSM-2256
Drug Alias NameSM-2256SM2256
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonistsTumor necrosis factor receptor superfamily member 9 agonistsInducible T-cell costimulator agonists
TargetsTumor necrosis factor receptor superfamily member 5Tumor necrosis factor receptor superfamily member 9Inducible T-cell costimulator
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhuhai StarMab BioMed Technology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai StarMab BioMed Technology Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A